{"questions":[{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21397175","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12794698","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19583827","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21403557","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11181569","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17414289","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24448525","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22016144","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16313397","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26740388"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17414289","offsetInEndSection":45,"text":"[Craniofacial morphology in Muenke syndrome.]","beginSection":"title"}],"id":"52bf1d3c03868f1b0600000d","body":"What symptoms characterize the Muenke syndrome","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27617148","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9302689","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12619118","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3025664","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20704938","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19086841","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8085754","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10805949","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2253239","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15784129"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27617148","offsetInEndSection":23,"text":"[Li-Fraumeni Syndrome.]","beginSection":"title"}],"id":"52bf208003868f1b06000019","body":"What is the inheritance pattern of Li-Fraumeni syndrome","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15049719","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10581997","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1947965","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2124655","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16913828","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11772304","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23986420","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19853801","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8521760","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3776819"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10581997","offsetInEndSection":34,"text":"[[Indications for thrombolytics].]","beginSection":"title"}],"id":"52bf209303868f1b0600001a","body":"What are the indications for alteplase","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15181248","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25785051","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9369317","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11578778","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16740622","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27648138","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10872839","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25899745","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14511323","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15181251"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15181248","offsetInEndSection":93,"text":"[A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.]","beginSection":"title"}],"id":"530cf4fe960c95ad0c000002","body":"Does Apolipoprotein E (ApoE) have anti-inflammatory activity","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1325885","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2838262","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9495836","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1649623","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25992489","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6453897","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3026703","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14769811","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11835907","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7473177"],"snippets":[{"offsetInBeginSection":485,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1649623","offsetInEndSection":593,"text":"These and other data have indicated that only one of the two domains of somatic ACE is catalytically active.","beginSection":"abstract"}],"id":"530cf4fe960c95ad0c000005","body":"Is the ACE inhibitor indicated for lung cancer treatment","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19538001","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12215069","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11929332","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/13825521","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2844497","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7093048","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1694931","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19366271","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3296979","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/13671327"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/13671327","offsetInEndSection":59,"text":"[indications for the use of hydrochlorothiazide in edema].]","beginSection":"title"}],"id":"530cf4fe960c95ad0c000007","body":"What are the indications for hydrochlorothiazide","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3321880","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/277475","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19649734","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10744730","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24237437","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/689274","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9361990","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2710586","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/13291893","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/5299000"],"snippets":[{"offsetInBeginSection":60,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3321880","offsetInEndSection":162,"text":"A window permitted daily microscopy of bone formation including observations of tetracyline labelling.","beginSection":"abstract"}],"id":"530cf4fe960c95ad0c000009","body":"Can tetracyline affect tooth formation","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8861737","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16867025","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8693299","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8521677","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7714808","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23034583","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9517435","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25217539","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2262904","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19007522"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8521677","offsetInEndSection":97,"text":"Zolpidem is an imidazopyridine which differs in structure from the benzodiazepines and zopiclone.","beginSection":"abstract"}],"id":"530cf4fe960c95ad0c00000a","body":"Is zolpidem an antibiotic","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26052929","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23664448","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27873136","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24435321","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24728512","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21732753","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25517450","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22452896","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11248153","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24754585"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23664448","offsetInEndSection":65,"text":"[Clinical perspective of afatinib in non-small cell lung cancer.]","beginSection":"title"}],"id":"530cf4fe960c95ad0c00000b","body":"Which type of lung cancer is afatinib used for","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25447484","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26475204","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25012446","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20926994","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26895080","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20960017","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25892629","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24406339","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19606083","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15213704"],"snippets":[{"offsetInBeginSection":420,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24406339","offsetInEndSection":530,"text":"A significant increase in subcutaneous and gonadal fat mass was only observed for the 50mg\/kg\/day dose of SIT.","beginSection":"abstract"}],"id":"530cf4fe960c95ad0c00000c","body":"Can desvenlafaxine be used at a dose of 50mg\/day","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11130261","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22023204","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24114623","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16227996","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26770269","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10703677","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26670403","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25428711","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22179489","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23078888"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23078888","offsetInEndSection":98,"text":"[Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.]","beginSection":"title"}],"id":"530cf4fe960c95ad0c00000d","body":"Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27005015","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20075436","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27105590","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25424139","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27396560","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26885733","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22936681","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27633869","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17429755","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27503805"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26885733","offsetInEndSection":64,"text":"[State of the Art: Clinical Applications of Cardiac T1 Mapping.]","beginSection":"title"}],"id":"530cf51d5610acba0c000001","body":"What is the clinical indication of cardiac T1 mapping magnetic resonance","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19030024","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19736564","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21368825","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25408883","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16253997","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23801083","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23706735","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10428218","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26561000","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23144633"],"snippets":[{"offsetInBeginSection":754,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26561000","offsetInEndSection":853,"text":"These factors in conjunction with Yamanaka factors increase the efficiency of hepatic reprograming.","beginSection":"abstract"}],"id":"53137541e3eabad021000010","body":"Which are the Yamanaka factors","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8630497","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18538122","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25295090","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18283249","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27620717","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9618167","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26744121","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10051166","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10700480","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9849679"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27620717","offsetInEndSection":40,"text":"[Delayed diagnosis of Pendred syndrome.]","beginSection":"title"}],"id":"53148a07dae131f847000002","body":"Which hormone abnormalities are characteristic to Pendred syndrome","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8062508","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26596027","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10087542","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8282365","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1535705","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1486606","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2351430","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1815220","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14526231","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1423477"],"snippets":[{"offsetInBeginSection":260,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26596027","offsetInEndSection":433,"text":"We studied dynamic of N-terminal pro-brain natriuretic peptide (n-proBNP) level in patients with acute brain injury (intracranial hemorrage, traumatic brain injury, tumors).","beginSection":"abstract"}],"id":"5314d05adae131f84700000d","body":"What is the role of brain natriuretic peptide in traumatic brain injury patients ","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19894263","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19146954","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20808602","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24641604","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21980925","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23960389","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21617430","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25196684","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21031076","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24333401"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21617430","offsetInEndSection":83,"text":"[A prospective controlled assessment of microneedling with the Dermaroller device.]","beginSection":"title"}],"id":"5325a1a69b2d7acc7e000025","body":"What are the applications of a Dermaroller ","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11309218","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11898506","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27161251","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16859269","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23808630","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20709416","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26661291","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16005720","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25276601","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26849709"],"snippets":[{"offsetInBeginSection":1122,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26661291","offsetInEndSection":1204,"text":"To localize the location of the CSF leak-CT myelography is the modality of choice.","beginSection":"abstract"}],"id":"5326300fd6d3ac6a34000005","body":"What imaging modalities have been listed as method of choice  to diagnose CSF leak","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24779591","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25882608","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21195646","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21565845","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12900703","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23415127","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8883004","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23060084","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22633656","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16987942"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21195646","offsetInEndSection":86,"text":"[Differences in activity-related behaviour among patients with chronic low back pain.]","beginSection":"title"}],"id":"533f9df0c45e133714000016","body":"What is being measured with an accelerometer in back pain patients","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6229541","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6308613","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4415761","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6201617","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6084166","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6084724","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6232278","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6235919","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4521801","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2409601"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4415761","offsetInEndSection":51,"text":"[Transcription boundaries of U1 small nuclear RNA.]","beginSection":"title"}],"id":"5357a514f1005d6b58000003","body":"How could U1 small nuclear RNA be used in therapeutics","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1825520","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7489523","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11214185","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10801464","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11172726","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8201617","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11574683","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10207048","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8596928","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11237011"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1825520","offsetInEndSection":74,"text":"[Mutational analysis of the U12-dependent branch site consensus sequence.]","beginSection":"title"}],"id":"5357a6d0f1005d6b58000004","body":"Which is the branch site consensus sequence in U12-dependent introns","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16337852","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10694887","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10673500","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14618615","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27273131","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15488637","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26332814","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11100718","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19219042","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19399639"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11100718","offsetInEndSection":91,"text":"[A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.]","beginSection":"title"}],"id":"5357b36cf1005d6b58000006","body":"Which is the main CHEK2 genetic variant, thought to be involved in familial breast cancer","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21070773","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11100718","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12654917","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21459569","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12097646","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18459160","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10617473","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7738036","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7622044","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15269203"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21070773","offsetInEndSection":73,"text":"[Per3, a circadian gene, is required for Chk2 activation in human cells.]","beginSection":"title"}],"id":"5357b5ecf1005d6b58000007","body":"Is PER3 required for CHK2 activation in human cells","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18812180","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23969844","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18538787","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15073169","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17172433","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11085506","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17620722","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12855956","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23569217","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16205633"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18812180","offsetInEndSection":67,"text":"[Exploring the intramolecular phosphorylation sites in human Chk2.]","beginSection":"title"}],"id":"5357b9bcf1005d6b58000008","body":"Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20080130","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10959836","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11454675","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11053450","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16798742","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8700224","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19221470","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16311512","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18508566","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18258790"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20080130","offsetInEndSection":96,"text":"[Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity.]","beginSection":"title"}],"id":"5357bd56f1005d6b58000009","body":"What is the effect of Chk2 splice variants on wild-type Chk2 kinase activity","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/210961","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16848684","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15376329","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/476525","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25887447","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6302268","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11006283","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/389432","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9511769","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7618269"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25887447","offsetInEndSection":65,"text":"[Long non-coding RNA regulation of reproduction and development.]","beginSection":"title"}],"id":"535d292a9a4572de6f000003","body":"Are long non coding RNAs spliced","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16924799","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20396722","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20879466","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8779182","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12905979","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21938893","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1562720","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14630274","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7183306","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15764469"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12905979","offsetInEndSection":52,"text":"[Is it time for quadruple therapy to be first line?]","beginSection":"title"}],"id":"535d69177d100faa09000003","body":"What is SCENAR therapy used for","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27826901","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27686107","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27262389","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25482319","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21071074","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17466815","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21478771","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26816664","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24133558","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21051617"],"snippets":[{"offsetInBeginSection":703,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27826901","offsetInEndSection":862,"text":"In addition, more work is needed to identify the role of mHealth technology in treating vulnerable populations to ameliorate cardiovascular health disparities.","beginSection":"abstract"}],"id":"535d7c247d100faa09000006","body":"What is known about the role of mHealth in the prevention of disease","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2703281","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1867424","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8444739","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12949026","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2764155","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8306198","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22814101","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2722127","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3826411","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/893254"],"snippets":[{"offsetInBeginSection":769,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22814101","offsetInEndSection":969,"text":"Based on our computational results, the difference in the threshold temperatures for activating the thermophysiological response, especially for sweating, is examined between older and younger adults.","beginSection":"abstract"}],"id":"536787467d100faa09000010","body":"Which is the relation between sweating and anaerobic threshold","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9090523","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7604851","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8411703","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21068576","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14972652","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/271968","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/13979552","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18490185","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8490625","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22670494"],"snippets":[{"offsetInBeginSection":310,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22670494","offsetInEndSection":374,"text":"Its most common variant is the infantile type Tay-Sachs disease.","beginSection":"abstract"}],"id":"536e46f27d100faa09000012","body":"Which is the gene most commonly mutated in Tay-Sachs disease","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14769950","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27648360","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12454644","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12860957","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27470518","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21617858","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26961138","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27426244","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16870303","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24435321"],"snippets":[{"offsetInBeginSection":1871,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27470518","offsetInEndSection":2015,"text":"However, concomitant treatment with potent inhibitors or inducers of the P-glycoprotein transporter can affect the pharmacokinetics of afatinib.","beginSection":"abstract"}],"id":"54297ed2289fd6cb07000001","body":"Can siRNA affect response to afatinib treatment","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14571276","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17578347","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22068070","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15176428","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17497254","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22481011","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26018045","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22422768","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20361477","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27212848"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20361477","offsetInEndSection":85,"text":"[[Genetic of catecholaminergic polymorphic ventricular tachycardia: basic concepts].]","beginSection":"title"}],"id":"54c225bcf693c3b16b000002","body":"Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19068246","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20457122","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16243911","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1767532","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15863505","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15697170","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10769397","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25069966","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9051577","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22503956"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10769397","offsetInEndSection":56,"text":"[Physiology and pathophysiology of calcium homeostasis.]","beginSection":"title"}],"id":"54c26e29f693c3b16b000003","body":"Is Calcium homeostasis important in cardiac physiology and pathophysiology","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25467564","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19602735","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8521589","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11909005","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18391874","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8672564","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16049318","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19962044","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12133653","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23637212"],"snippets":[{"offsetInBeginSection":366,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25467564","offsetInEndSection":483,"text":"Because of the seriousness of the condition, a declaration of war on five fronts has been proposed for heart failure.","beginSection":"abstract"}],"id":"54c90dabf693c3b16b000004","body":"Which genes have been proposed as potential candidates for gene therapy of heart failure","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18836677","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11679415","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15059971","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15909986","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1464616","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7983062","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21900893","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10551848","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10807524","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15256372"],"snippets":[{"offsetInBeginSection":292,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10807524","offsetInEndSection":384,"text":"The function of SERCA2a protein is regulated by the phosphorylatable protein, phospholamban.","beginSection":"abstract"}],"id":"54cb9c94f693c3b16b000005","body":"Which is the main regulatory molecule of SERCA2A function in the cardiac muscle","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24403965","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1580196","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23421586","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21833044","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19347261","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19416416","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16493645","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24973965","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18681618","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25271805"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24403965","offsetInEndSection":37,"text":"[Armoured brain of unknown etiology.]","beginSection":"title"}],"id":"54cf42bdf693c3b16b000007","body":"Describe armoured brain syndrome.","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9780908","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19396832","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24320339","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/872516","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23277941","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22017771","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3168525","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11104980","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20048621","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17994831"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9780908","offsetInEndSection":75,"text":"[Bilambdoid and posterior sagittal synostosis: the Mercedes Benz syndrome.]","beginSection":"title"}],"id":"54cf43abf693c3b16b000008","body":"Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11569897","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8685694","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16921895","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10460438","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25107692","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8752471","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21598464","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12808463","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2280887","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11814734"],"snippets":[{"offsetInBeginSection":523,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11569897","offsetInEndSection":722,"text":"We could show that it is possible to visualize major brain landmarks including the \"butterfly shaped\" midbrain, basal cisterns, third and lateral ventricles in all animals by transcranial ultrasound.","beginSection":"abstract"}],"id":"54cf449cf693c3b16b000009","body":"Is it possible to visualize subtahalamic nucleus by using transcranial ultrasound","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/157875","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6766447","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2877689","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/131803","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15036331","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6303413","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8569724","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6227613","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14142","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19278523"],"snippets":[{"offsetInBeginSection":227,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6766447","offsetInEndSection":299,"text":"Only one of these proteins is the high affinity calcium binding protein.","beginSection":"abstract"}],"id":"54cf45e7f693c3b16b00000a","body":"Which is the main calcium binding protein of the sarcoplasmic reticulum","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21497181","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21163582","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26652051","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19660659","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25558238","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16632872","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11856793","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20129501","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18447940","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15780504"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11856793","offsetInEndSection":168,"text":"[Diverse effects of hypothermia therapy in patients with severe traumatic brain injury based on the computed tomography classification of the traumatic coma data bank.]","beginSection":"title"}],"id":"54cf48acf693c3b16b00000b","body":"Is progesterone effective for treatment of patients with traumatic brain injury based on clinical trial data","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23859128","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25238731","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18656214","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12127170","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21263143","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27345098","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23460396","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8990055","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11391766","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23703310"],"snippets":[{"offsetInBeginSection":643,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27345098","offsetInEndSection":767,"text":"PGB is also effective for the treatment of generalized anxiety disorder and GBP for the treatment of restless legs syndrome.","beginSection":"abstract"}],"id":"54cf4a0ef693c3b16b00000c","body":"Is pregabalin effective for treatment of patients with restless leg syndrome","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15053241","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17851695","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1907253","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15456942","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23605905","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9857110","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1854882","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17519976","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8136816","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15628053"],"snippets":[{"offsetInBeginSection":1198,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1907253","offsetInEndSection":1359,"text":"There was a positive correlation between maximal interleukin 6 concentrations and maximal increases in the serum concentrations of C-reactive protein (r = 0.66).","beginSection":"abstract"}],"id":"54cf4bc3f693c3b16b00000d","body":"Is there an association between serum interleukin-6 concentrations and outcomes of stroke patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9530537","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10604520","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12639808","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17620062","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20922352","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2185292","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12222553","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12222554","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25241359","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17966084"],"snippets":[{"offsetInBeginSection":359,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20922352","offsetInEndSection":538,"text":"A patient with acute ACE inhibitor-induced angioedema was treated with icatibant, a specific bradykinin B2 receptor antagonist approved for the treatment of hereditary angioedema.","beginSection":"abstract"}],"id":"54cf6d40f693c3b16b00000e","body":"Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25712882","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2031254","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12282068","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7270557","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23818257","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1635124","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21777696","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1519240","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23216411","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17632891"],"snippets":[{"offsetInBeginSection":1119,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23216411","offsetInEndSection":1174,"text":"The highest variation of 4.8% was observed in cucumber.","beginSection":"abstract"}],"id":"54cf7051f693c3b16b000013","body":"Treatment of which disease was investigated in the MR CLEAN study","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21739168","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26209605","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16729916","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21914576","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20496895","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25251673","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11521188","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23152080","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18779539","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21512659"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21914576","offsetInEndSection":80,"text":"[[The inhibitor of integrins Cilengitide: a new active drug in neuro-oncology].]","beginSection":"title"}],"id":"54cf705ff693c3b16b000014","body":"List receptors of the drug Cilengitide","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16759446","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1853412","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19658274","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17536487","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21299874","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21125466","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22170177","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11426093","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22890642","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20538692"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21299874","offsetInEndSection":95,"text":"[Magnesium sulfate for aneurysmal subarachnoid hemorrhage: the end of the road or more trials?]","beginSection":"title"}],"id":"54d62ede3706e89528000002","body":"Does magnesium sulfate improve outcomes of subarachnoid hemorrhage patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14530797","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15246819","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17101741","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17408618","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17579658","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15857295","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16696147","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17244778","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17849454","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17874968"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16696147","offsetInEndSection":36,"text":"[NXY-059 for acute ischemic stroke.]","beginSection":"title"}],"id":"54d62faf3706e89528000003","body":"Can NXY-059 be used for treatment of acute ischemic stroke patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25269031","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9218294","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23662801","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20063259","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24236823","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18389176","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21756557","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25085219","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18366283","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8304553"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21756557","offsetInEndSection":105,"text":"[The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival.]","beginSection":"title"}],"id":"54d630283706e89528000004","body":"Do carmustine wafers improve survival of glioblastoma patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21747397","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21483432","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26206863","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20537397","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23325106","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11252650","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9756925","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24461634","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16449553","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17211523"],"snippets":[{"offsetInBeginSection":1221,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9756925","offsetInEndSection":1295,"text":"The latter factors control the transcription of the ITIH3 gene positively.","beginSection":"abstract"}],"id":"54d63d873706e89528000006","body":"Is there any association of the chromosomal region harboring the gene ITIH3 with schizophrenia","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14690594","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11733541","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19160676","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11846405","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23086420","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10790201","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14722070","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10790201","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12646134","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9305655"],"snippets":[{"offsetInBeginSection":668,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23086420","offsetInEndSection":793,"text":"As a paradox, 6 of the 14 members of the myotubularin family lack enzymatic activity and are considered as dead phosphatases.","beginSection":"abstract"}],"id":"54d6562c3706e8952800000b","body":"Which is the enzymatic activity of the myotubularin family of proteins","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23397482","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25420424","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27102125","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24034235","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7462147","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26384571","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27269589","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25482236","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26208692","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16171691"],"snippets":[{"offsetInBeginSection":776,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24034235","offsetInEndSection":836,"text":"Also the itaconic acid productivity increased significantly.","beginSection":"abstract"}],"id":"54d669003706e8952800000e","body":"When are itaconic acid levels elevated","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19634821","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8982144","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20058444","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17514010","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21162511","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22019779","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22205679","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25991642","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24168116","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26647570"],"snippets":[{"offsetInBeginSection":396,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22019779","offsetInEndSection":459,"text":"associated with adolescent idiopathic scoliosis susceptibility.","beginSection":"abstract"}],"id":"54d670163706e8952800000f","body":"List Genes associated with adolescent idiopathic scoliosis","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17564181","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18389144","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12342313","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19130220","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9056591","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25733976","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18579013","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26193946","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22214588","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27181716"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9056591","offsetInEndSection":100,"text":"The problem of drug interchangeability among a brand-name drug and its generic copies is considered.","beginSection":"abstract"}],"id":"54d73e223706e89528000010","body":"What is the generic name of Gliolan","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15632787","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24971014","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20651011","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17239658","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15065968","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11757776","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21654719","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11598889","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15675652","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22926087"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24971014","offsetInEndSection":113,"text":"[Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients.]","beginSection":"title"}],"id":"54d762653706e89528000014","body":"Can cognitive behavioral therapy improve fatigue in cancer patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3080695","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3091628","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2127925","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3098927","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3923160","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6424472","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3092130","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3080694","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2997661","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3097367"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3097367","offsetInEndSection":86,"text":"[Treatment of amyotrophic lateral sclerosis with thyrotropin-releasing hormone (TRH).]","beginSection":"title"}],"id":"54d76ac63706e89528000016","body":"Is there any data to suggest that TRH (thyrotropin releasing hormone) administration can improve symptom severity of amyotrophic lateral sclerosis patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15867328","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2749846","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14723030","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26028028","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23441831","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10760289","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20977665","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21643007","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17433772","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16826045"],"snippets":[{"offsetInBeginSection":835,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10760289","offsetInEndSection":919,"text":"Furthermore, HAMLET sensitivity was modified by the glycolytic state of tumor cells.","beginSection":"abstract"}],"id":"54d776453706e89528000018","body":"What was the aim of the HAMLET clinical trial","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3310713","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18040908","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15307473","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23606989","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10463231","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6513945","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26239489","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3844442","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10522528","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2176927"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6513945","offsetInEndSection":114,"text":"[[Sonographic characteristics of the Arnold-Chiari syndrome and hydrocephalus in children with meningomyelocele].]","beginSection":"title"}],"id":"54d77bdf3706e89528000019","body":"List chromosomes that have been linked to Arnold Chiari syndrome in the literature.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17220536","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17826005","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18076335","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25760363","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24574554","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15765262","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27421270","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17530728","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25839895","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23421099"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25760363","offsetInEndSection":49,"text":"[Cytisine versus nicotine for smoking cessation.]","beginSection":"title"}],"id":"54d77f0e3706e8952800001b","body":"Is cytisine superior to nicotine replacement therapy for smoking cessation","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25801344","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18400176","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15067723","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25636595","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23370853","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1718228","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26458419","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25642219","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21245532","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24724574"],"snippets":[{"offsetInBeginSection":1135,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25801344","offsetInEndSection":1283,"text":"More recently, carbamylation of proteins has also been implicated in the pathogenesis of rheumatoid arthritis in a manner similar to citrullination.","beginSection":"abstract"}],"id":"54d796f93706e8952800001e","body":"Has protein citrullination been implicated in rheumatoid arthritis","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18246300","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23086926","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11443914","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15628698","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7514035","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10092530","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15064314","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17468498","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25596488","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11984825"],"snippets":[{"offsetInBeginSection":378,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18246300","offsetInEndSection":553,"text":"The fused protein angiogenin-EGF was then expressed in HUVECs, and the subcellular localization of the recombinant protein was determined by confocal microscopy and TEM assay.","beginSection":"abstract"}],"id":"54d7a1047035c08008000002","body":"Which is the subcellular localization of the protein angiogenin","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27436854","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2719939","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10486275","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18055286","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11563327","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3663649","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2775757","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26823555","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10070263","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26513712"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10070263","offsetInEndSection":88,"text":"[Comparison of the dynamics of bovine and human angiogenin: a molecular dynamics study.]","beginSection":"title"}],"id":"54d7ae1fe19bba8909000001","body":"Which is the molecular weight of the protein angiogenin","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20171123","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26825538","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14719684","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23188089","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18796930","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26199893","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17185288","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26389604","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22797750","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9545378"],"snippets":[{"offsetInBeginSection":538,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26825538","offsetInEndSection":617,"text":"Proteins were quantified by the 'Total Protein Approach' and 'Proteomic Ruler'.","beginSection":"abstract"}],"id":"54d7b457e19bba8909000004","body":"What is the \"Proteomic ruler\"","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8794835","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9519348","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2936238","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7777669","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18034302","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12691636","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9200394","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19945295","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3605130","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3948357"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12691636","offsetInEndSection":163,"text":"Accumulation of oxidized matrix between the endothelium and cardiac muscle, and endocardial endothelial dysfunction, are the hallmarks of congestive heart failure.","beginSection":"abstract"}],"id":"54d892ee014675820d000005","body":"What are the hallmarks of congestive heart failure","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20003593","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22249490","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7651445","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14703107","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21819188","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/422962","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3480935","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20862340","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25939970","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12884831"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20003593","offsetInEndSection":59,"text":"[Stridor in Parkinson's disease: a case of 'dry drowning'?]","beginSection":"title"}],"id":"54d8d4d1014675820d000006","body":"Do Parkinson's disease patients experience stridor","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26707829","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25993155","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24325952","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24413374","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22253555","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25720800","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23934108","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27042173","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25653539","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19323560"],"snippets":[{"offsetInBeginSection":353,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24325952","offsetInEndSection":442,"text":"Two inhibitors, vemurafenib and dabrafenib, have been approved for treatment of melanoma.","beginSection":"abstract"}],"id":"54d8d60d014675820d000007","body":"List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27212848","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20923637","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26018045","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18634915","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22068070","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20143088","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7816057","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10653680","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27180891","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16823244"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20923637","offsetInEndSection":128,"text":"The mechanism of therapeutic efficacy of flecainide for catecholaminergic polymorphic ventricular tachycardia (CPVT) is unclear.","beginSection":"abstract"}],"id":"54d8e319014675820d000009","body":"What are the main characteristics of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27309272","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26162957","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25707748","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19958397","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23795692","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27957071","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19888755","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22923098","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3500549","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/498448"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19888755","offsetInEndSection":69,"text":"Atrial fibrillation is the most prevalent form of cardiac arrhythmia.","beginSection":"abstract"}],"id":"54d8ea2c4b1fd0d33c000002","body":"Which is the most prevalent form of arrhythmia worldwide","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22239008","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11548570","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25114827","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11333057","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20128157","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9780768","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25955277","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17089931","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11099355","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22844180"],"snippets":[{"offsetInBeginSection":125,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9780768","offsetInEndSection":180,"text":"We review the main characteristics of Brugada syndrome.","beginSection":"abstract"}],"id":"54d8efb84b1fd0d33c000003","body":"What are the main characteristics\/symptoms of the \"Brugada\" syndrome","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19383796","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17526652","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24805197","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24152985","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24224592","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2766509","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16138947","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22889703","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15863505","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16001775"],"snippets":[{"offsetInBeginSection":2266,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2766509","offsetInEndSection":2361,"text":"Sudden cardiac death is the most common cause of mortality in patients with myotonic dystrophy.","beginSection":"abstract"}],"id":"54d8f37b4b1fd0d33c000004","body":"Is the HRC Ser96Ala variant associated with sudden cardiac death in patients with dilated cardiomyopathy","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14519652","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7703440","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21154166","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25663738","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26732311","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25964313","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22309662","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20383346","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26100271","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25985004"],"snippets":[{"offsetInBeginSection":1082,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21154166","offsetInEndSection":1172,"text":"Given these results, rindopepimut is an extremely promising therapy for patients with GBM.","beginSection":"abstract"}],"id":"54d8fd334b1fd0d33c000005","body":"Rindopepimut is an analog of which growth factor","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21483304","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21485758","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25926743","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25816654","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18094616","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1584765","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24571331","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25616647","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11912174","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24012640"],"snippets":[{"offsetInBeginSection":1232,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25816654","offsetInEndSection":1489,"text":"Unbiassed analysis of clinical trials on monoclonal antibodies does not allow us to conclude that passive immunotherapy directed against antigens listed above can significantly improve the overall survival of patients suffering from glioblastoma multiforme.","beginSection":"abstract"}],"id":"54d901ec4b1fd0d33c000006","body":"Does nimotuzumab improve survival of glioblastoma patients","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16403636","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16341272","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23645985","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21805246","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15108180","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17359920","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27793800","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18407786","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12194816","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20883327"],"snippets":[{"offsetInBeginSection":99,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20883327","offsetInEndSection":169,"text":"DNA methylation is an essential signal for epigenetic gene regulation.","beginSection":"abstract"}],"id":"54d9f7894b1fd0d33c00000a","body":"Is DNA methylation an epigenetic modification of chromatin related to gene expression","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3730367","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9350040","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2954508","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3007493","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3759968","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2950100","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3082370","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7857766","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6143239","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6229539"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3759968","offsetInEndSection":160,"text":"Phospholamban is a regulatory protein in cardiac sarcoplasmic reticulum that is phosphorylated by cAMP- and Ca2+\/calmodulin-dependent protein kinase activities.","beginSection":"abstract"}],"id":"54da0c524b1fd0d33c00000b","body":"Is phospholamban phosphorylated by Protein kinase A","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19252257","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25820735","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15571781","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27424760","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23085117","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15158487","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26044030","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8497844","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18571732","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8811917"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25820735","offsetInEndSection":99,"text":"[Western blotting using in-gel protein labeling as a normalization control: stain-free technology.]","beginSection":"title"}],"id":"54da21bf4b1fd0d33c00000d","body":"Describe what is the advantage of using a stain free protein gel in a Western Blot experiment","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25107546","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27440957","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7641328","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1742923","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18393876","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12587684","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11825323","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20132234","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2107784","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2105049"],"snippets":[{"offsetInBeginSection":390,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12587684","offsetInEndSection":515,"text":"Flecainide is a class IC anti-arrhythmic drug causing a decreased intracardiac conduction velocity in all parts of the heart.","beginSection":"abstract"}],"id":"54da32bc0f63c58e6e000001","body":"Which is the main target of the anti-arrhythmic activity of flecainide","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10655057","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11237011","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26859682","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23657981","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18823011","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12588445","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17139617","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20393868","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17483816","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20716667"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10655057","offsetInEndSection":91,"text":"[Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.]","beginSection":"title"}],"id":"54db1d580f63c58e6e000005","body":"Is Alu hypomethylation associated with breast cancer","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1885007","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21474744","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1831879","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16314460","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8201617","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21474744","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10024169","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11333026","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8313914","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16857676"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21474744","offsetInEndSection":104,"text":"[Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I.]","beginSection":"title"}],"id":"54db5e24bcba1b1817000002","body":"What is the disorder in which mutations in U4atac snRNA are detected","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/131803","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6227613","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2964872","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2962642","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/403186","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8402836","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8275521","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3160695","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6303413","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/176697"],"snippets":[{"offsetInBeginSection":1616,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/176697","offsetInEndSection":1734,"text":"These results may suggest that phospholamban is a modulator of the calcium pump of the cardiac sarcoplasmic reticulum.","beginSection":"abstract"}],"id":"54db62a3034aea571d000001","body":"Which is the main calcium pump of the sarcoplasmic reticulum","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8001396","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8626432","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18221109","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8729698","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18182155","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7896740","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9439828","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8023884","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12456308","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10864448"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9439828","offsetInEndSection":133,"text":"[Differential distribution and subcellular localization of ryanodine receptor isoforms in the chicken cerebellum during development.]","beginSection":"title"}],"id":"54db7217c4c6ce8e1d000003","body":"How many and which are the different isoforms for the ryanodine receptor","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6273007","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2971537","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/165680","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2954508","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15709678","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6143239","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8700163","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6541524","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2997184","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2775741"],"snippets":[{"offsetInBeginSection":1280,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/165680","offsetInEndSection":1527,"text":"Phospholamban has not been found in fast skeletal muscle, nor is Ca2+ transport accelerated by cyclic AMP and protein kinase in sarcoplasmic reticulum from these muslces which do not respond to beta-adrenergic agonists with accelerated relaxation.","beginSection":"abstract"}],"id":"54db7c4ac0bb8dce23000001","body":"Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8923268","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18704300","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21586292","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12688667","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7511166","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8239655","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6254958","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20107081","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11756484","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8262215"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12688667","offsetInEndSection":84,"text":"[Calcium-induced calcium release and calcium buffering in retinal horizontal cells.]","beginSection":"title"}],"id":"54dc8ed6c0bb8dce23000002","body":"What is known as Calcium Induced Calcium Release (CICR) and its role in cardiomyocyte contractility","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16645399","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19476122","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029877","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8020027","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3249261","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8346707","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14661170","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19937997","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2533623","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25340269"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19937997","offsetInEndSection":114,"text":"Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease with a frequency as high as 1 in 200.","beginSection":"abstract"}],"id":"54dcb29dc0bb8dce23000004","body":"Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12897783","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11988762","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1709156","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17514354","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7512262","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2415825","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9041122","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15922354","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20713470","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23381119"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23381119","offsetInEndSection":75,"text":"There are ~650,000 Alu elements in transcribed regions of the human genome.","beginSection":"abstract"}],"id":"54dcd8f61388e8454a000001","body":"Are Alu elements transcribed","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25206352","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11907217","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19494014","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15296757","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11595597","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14999100","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18619467","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15296758","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9811770"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12167863","offsetInEndSection":296,"text":"While members of the APOBEC3 family of human intrinsic resistance factors are able to restrict the replication of Vif-deficient forms of human immunodeficiency virus type 1 (HIV-1), they are unable to block replication of wild-type HIV-1 due to the action of Vif, which induces their degradation.","beginSection":"abstract"}],"id":"54de15f91388e8454a000002","body":"Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7763029","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10650787","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22772380","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7693420","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17879158","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19636702","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1834115","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15945507","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26520144","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25399229"],"snippets":[{"offsetInBeginSection":117,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25399229","offsetInEndSection":197,"text":"However, which is the preferable taxane in a dose-dense regimen remains unknown.","beginSection":"abstract"}],"id":"54df69af1388e8454a000005","body":"Which drugs are included in the FEC-75 regimen","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23535992","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21344976","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17230505","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27954361","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24600235","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20870254","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2145898","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21983866","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20122270","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26682634"],"snippets":[{"offsetInBeginSection":239,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21983866","offsetInEndSection":344,"text":"The combination of Gliadel with the Stupp protocol has mostly been investigated in retrospective studies.","beginSection":"abstract"}],"id":"54df6ed91388e8454a000007","body":"List non-surgical treatment modalities that are included in the Stupp protocol.","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20870441","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27820156","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23649045","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24789113","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16947627","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11437676","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25801344","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23385088","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9428608","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12041674"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20870441","offsetInEndSection":119,"text":"[Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature.]","beginSection":"title"}],"id":"533c3533c45e133714000004","body":"Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis","type":"list"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16251966","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12672935","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25651893","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23485968","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11990307","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17157260","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22586128","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23828888","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26433205","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1423611"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16251966","offsetInEndSection":69,"text":"[Genetic and epigenetic regulation of human lincRNA gene expression.]","beginSection":"title"}],"id":"533c3571c45e133714000005","body":"How are lincRNA affecting the regulation of gene expression","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18798982","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27871973","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27765618","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21914728","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21572407","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26776207","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26851340","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14615540","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14615540","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21221132"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14615540","offsetInEndSection":94,"text":"[PAR-CliP--a method to identify transcriptome-wide the binding sites of RNA binding proteins.]","beginSection":"title"}],"id":"533c388dc45e133714000008","body":"What is the principle of the PAR-CLIP methodology","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16845028","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19563753","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16953792","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11931758","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10734189","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23052551","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27067545","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15371553","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2284094","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18552846"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19563753","offsetInEndSection":82,"text":"[Adaptive evolution and the birth of CTCF binding sites in the Drosophila genome.]","beginSection":"title"}],"id":"533c38b3c45e133714000009","body":"What is an approximate number of CTCF binding sites in the human genome","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24896178","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20150320","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18987734","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25169955","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26175660","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21955857","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22038007","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21310087","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24166758","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27167109"],"snippets":[{"offsetInBeginSection":243,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26175660","offsetInEndSection":377,"text":"Unfortunately, identifying an exome sequencing depth adequate for clinical use is a challenge that has not been addressed extensively.","beginSection":"abstract"}],"id":"533c390bc45e13371400000b","body":"What is an acceptable sequence coverage(depth) required for human whole-exome sequencing","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8725945","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22268800","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25588078","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18450493","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23389914","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25953618","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19591856","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14981256","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11581160","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25678110"],"snippets":[{"offsetInBeginSection":147,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8725945","offsetInEndSection":209,"text":"However, the in vivo functions of HuR are not well understood.","beginSection":"abstract"}],"id":"533c394ec45e13371400000c","body":"Which are the main functions of the human HuR (ELAVL1) protein in fibroblasts","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19966280","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24630716","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27684555","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26987750","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24449147","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23799614","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26307061","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7683367","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27297116","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19239884"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24630716","offsetInEndSection":75,"text":"[Synonymous mutations frequently act as driver mutations in human cancers.]","beginSection":"title"}],"id":"534427f8aeec6fbd07000009","body":"Are most driver gene mutations synonymous or non-synonymous","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16787682","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26718127","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22067145","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25057442","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25819079","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27792127","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22495314","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26705695","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27243824","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14993899"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27792127","offsetInEndSection":83,"text":"[Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors.]","beginSection":"title"}],"id":"534428feaeec6fbd0700000a","body":"What are cancer driver genes","type":"summary"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10839546","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10491386","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21970734","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16633335","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7896263","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18237772","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10839546","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25414305","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16936740","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23052551"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21970734","offsetInEndSection":61,"text":"[CTCF, cohesin, and histone variants: connecting the genome.]","beginSection":"title"}],"id":"5344310baeec6fbd0700000c","body":"Does the CTCF protein co-localize with cohesin","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11243912","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20302569","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2596552","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6638976","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21434853","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6285890","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6734434","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3325651","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3461747","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6254923"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3325651","offsetInEndSection":92,"text":"[The effect of doxorubicin (adriamycin) on cytoplasmic microtubule system in cardiac cells.]","beginSection":"title"}],"id":"53551206a0726bee57000001","body":"What is the major adverse effect of adriamycin(doxorubicin)","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19000097","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23687004","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17181768","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15385857","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25713669","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17390923","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11689727","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26369504","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20390664","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10932809"],"snippets":[{"offsetInBeginSection":0,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11689727","offsetInEndSection":84,"text":"There is a high prevalence of stress and urge incontinence in female elite athletes.","beginSection":"abstract"}],"id":"5361677c7d100faa09000008","body":"Is there increased incidence of incontinence in athletes","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12806798","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10838378","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22687358","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20065490","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1593784","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14978651","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17952465","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10602244","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3139732","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20025020"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3139732","offsetInEndSection":69,"text":"[Evaluation and treatment of urinary incontinence in long term care.]","beginSection":"title"}],"id":"536172d17d100faa09000009","body":"Has silicon been used in treatment of  incontinence ","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10551340","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17846815","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8744783","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6540676","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8699838","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24240086","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12092175","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8865352","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17594077","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22027849"],"snippets":[{"offsetInBeginSection":0,"endSection":"title","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17846815","offsetInEndSection":75,"text":"[Psychopathology in elite rhythmic gymnasts and anorexia nervosa patients.]","beginSection":"title"}],"id":"53617eeb7d100faa0900000a","body":"What is the name for anorexia in gymnasts","type":"factoid"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25405321","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24616020","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22089542","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26314468","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11965543","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23121285","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20682795","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21225432","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17504027","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16106041"],"snippets":[{"offsetInBeginSection":757,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26314468","offsetInEndSection":888,"text":"The miR-148\/152 family is regulated by methylation of their CPG islands, which reduce the expression of miR-148\/152 family members.","beginSection":"abstract"}],"id":"53636e727d100faa0900000d","body":"Are microRNA (miR) regulated through DNA methylation of their promoters","type":"yesno"},{"documents":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26106594","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27927715","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25971364","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17387145","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1423611","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24798520","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24573322","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10875929","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16682450","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18636078"],"snippets":[{"offsetInBeginSection":265,"endSection":"abstract","document":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24573322","offsetInEndSection":354,"text":"However, the role of lincRNA-p21 in human hepatocellular carcinoma remains to be defined.","beginSection":"abstract"}],"id":"5363bad27d100faa0900000e","body":"Which are the most abundant human lincRNA","type":"list"}]}